Betta Pharmaceuticals
Hangzhou, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A commercial-stage company developing and marketing targeted small molecule therapies for oncology and metabolic diseases.
OncologyMetabolic
Technology Platform
A small molecule drug discovery platform focused on kinase inhibitor optimization and structure-based design for oncology and metabolic targets.
Opportunities
Leveraging its commercial platform and cash flow to in-license and develop a broader portfolio of novel drugs for the Chinese market.
Risk Factors
Revenue over-reliance on a single mature product and pipeline candidates facing stiff competition from newer therapies.
Competitive Landscape
Competes with large pharma and other Chinese companies like Hengrui Medicine in the crowded targeted oncology therapy space.